Jul 09, 2018
Bausch + Lomb Announces U.S. FDA Filing Acceptance For Loteprednol Etabonate Ophthalmic Gel, 0.38%
Jun 26, 2018
Salix And US WorldMeds Enter Into Exclusive Co-Promotion Agreement For Opioid Withdrawal Treatment LUCEMYRA(TM) (lofexidine)
Jun 18, 2018
FDA Issues Complete Response Letter For DUOBRII(TM) (Halobetasol Propionate and Tazarotene) Lotion
May 31, 2018
Salix To Highlight New Clinical Data During Digestive Disease Week
May 17, 2018
Valeant Announces Launch Of Private Offering Of Notes And Upsize Of Term Loans
May 17, 2018
Valeant Announces Pricing Of Private Offering Of Notes
May 15, 2018
Valeant to Participate at the 2018 Barclays High Yield Bond and Syndicated Loan Conference
May 10, 2018
Valeant To Participate At 2018 Bank Of America Merrill Lynch Healthcare Conference
May 10, 2018
Valeant To Seek Refinancing of its Existing Credit Agreement
May 08, 2018
Valeant Will Become Bausch Health Companies Inc.
May 08, 2018
Valeant Announces First-Quarter 2018 Results And Raises Revenue And Adjusted EBITDA (non-GAAP) Guidance
May 07, 2018
Salix Receives FDA Approval For PLENVU®, Next Generation 1-Liter Bowel Cleansing Preparation For Colonoscopies
May 03, 2018
Valeant To Participate At Goldman Sachs Third Annual Leveraged Finance Conference
May 02, 2018
Summary Judgment Granted Upholding The Validity Of Formulation Patent Protecting RELISTOR® Injection
Apr 27, 2018
Bausch + Lomb Will Present Scientific And Clinical Research During The Association For Research In Vision And Ophthalmology Meeting
Apr 19, 2018
Bausch + Lomb Reports More Than Two Million Used Contact Lens Materials Recycled Through ONE by ONE Program
Apr 12, 2018
Valeant Announces Redemption of $150 Million Aggregate Principal Amount of Its Outstanding 6.375% Senior Unsecured Notes Due 2020
Apr 11, 2018
Bausch + Lomb to Showcase New Scientific Data During the Annual Meeting of the American Society of Cataract and Refractive Surgery
Apr 10, 2018
Valeant And One Of Its Subsidiaries Announce Expiration And Final Settlement Date For Cash Tender Offers For Senior Notes
Apr 09, 2018
Ortho Dermatologics Announces Publication Of Pivotal Efficacy And Safety Data For Psoriasis Treatment DUOBRII(TM) In The Journal of the American Academy of Dermatology